Related Experiment Video
Updated: Jul 8, 2025
10:32
Transvaginal Mesh Insertion in the Ovine Model
Published on: July 27, 2017
16.1K
Advanced flexible transvaginal mesh with high visibility under computerized tomography (CT) scan
Summary
A new bioengineered transvaginal surgical mesh (TVM) offers improved outcomes for pelvic floor disorders. This innovative mesh is imaging-compatible, mimics human tissue, and may reduce complications like pain and inflammation.
Area of Science:
- Biomedical Engineering
- Women's Health
- Surgical Innovation
Background:
- Pelvic floor disorders, including pelvic organ prolapse (POP) and stress urinary incontinence (SUI), are prevalent and impact women's quality of life.
- Transvaginal surgical mesh (TVM) is a common surgical treatment, but up to 15% of implants lead to significant long-term complications such as pain, infection, and symptom recurrence.
- Current TVM limitations necessitate the development of safer and more effective alternatives.
Purpose of the Study:
- To introduce and evaluate a novel bioengineered transvaginal surgical mesh (TVM) designed to overcome the limitations of existing implants.
- To assess the potential of the new TVM to reduce patient-reported complications and improve surgical outcomes in women's health.
- To highlight the technological advancements in imaging compatibility and tissue integration.
Main Methods:
- Development of a bioengineered TVM with a structural profile closely resembling human vaginal tissue.
- Incorporation of features enabling visualization via noninvasive imaging techniques, such as computed tomography (CT).
- Pre-clinical evaluation focusing on biocompatibility, structural integrity, and potential for reduced inflammatory response.
Main Results:
- The bioengineered TVM demonstrates a structural similarity to native human tissue.
- The mesh is compatible with noninvasive imaging modalities like CT, facilitating post-operative monitoring.
- Preliminary assessments suggest a potential for reduced pain and inflammation compared to conventional TVM.
Conclusions:
- The novel bioengineered TVM represents a significant advancement in addressing complications associated with traditional transvaginal mesh.
- Its imaging compatibility and biomimetic properties offer potential for improved patient care and surgical outcomes.
- This technological innovation holds promise for revolutionizing the treatment of pelvic floor disorders in women.
